Literature DB >> 25013385

Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers.

Aaron D Besterman1, Scott A Wilke1, Tua-Elisabeth Mulligan1, Stephen C Allison1, Randi Hagerman2, Andreea L Seritan3, James A Bourgeois1.   

Abstract

Fragile X-associated disorders (FXD) are a group of disorders caused by expansion of non-coding CGG repeat elements in the fragile X (FMR1) gene. One of these disorders, fragile X syndrome (FXS), is the most common heritable cause of intellectual disability, and is caused by large CGG repeat expansions (>200) resulting in silencing of the FMR1 gene. An increasingly recognized number of neuropsychiatric FXD have recently been identified that are caused by 'premutation' range expansions (55-200). These disorders are characterized by a spectrum of neuropsychiatric manifestations ranging from an increased risk of neurodevelopmental, mood and anxiety disorders to neurodegenerative phenotypes such as the fragile X-associated tremor ataxia syndrome (FXTAS). Here, we review advances in the clinical understanding of neuropsychiatric disorders in premutation carriers across the lifespan and offer guidance for the detection of such disorders by practicing psychiatrists and neurologists.

Entities:  

Keywords:  ADHD; ASD; Anxiety; Autism; Depression; FMR1; FXTAS; Fragile X Premutation; Fragile X Syndrome; Fragile X-associated Tremor Ataxia Syndrome

Year:  2014        PMID: 25013385      PMCID: PMC4086747          DOI: 10.2217/fnl.14.11

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  95 in total

Review 1.  FMR1 and the continuum of primary ovarian insufficiency.

Authors:  Shannon D Sullivan; Corrine Welt; Stephanie Sherman
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

4.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

5.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

Review 6.  Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome.

Authors:  Claudine M Kraan; Darren R Hocking; John L Bradshaw; Joanne Fielding; Jonathan Cohen; Nellie Georgiou-Karistianis; Kim M Cornish
Journal:  Neurosci Biobehav Rev       Date:  2013-01-23       Impact factor: 8.989

7.  Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation.

Authors:  Kami Koldewyn; David Hessl; John Adams; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Susan M Rivera
Journal:  Brain Imaging Behav       Date:  2008-01-18       Impact factor: 3.978

8.  Lifespan changes in working memory in fragile X premutation males.

Authors:  Kim M Cornish; Cary S Kogan; Lexin Li; Jeremy Turk; Sebastien Jacquemont; Randi J Hagerman
Journal:  Brain Cogn       Date:  2008-12-27       Impact factor: 2.310

9.  High apolipoprotein E4 allele frequency in FXTAS patients.

Authors:  Francisca Silva; Laia Rodriguez-Revenga; Irene Madrigal; Maria Isabel Alvarez-Mora; Rafael Oliva; Montserrat Milà
Journal:  Genet Med       Date:  2013-03-14       Impact factor: 8.822

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  13 in total

Review 1.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

Review 2.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 3.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

4.  Selective rescue of heightened anxiety but not gait ataxia in a premutation 90CGG mouse model of Fragile X-associated tremor/ataxia syndrome.

Authors:  Hoanna Castro; Emre Kul; Ronald A M Buijsen; Lies-Anne W F M Severijnen; Rob Willemsen; Renate K Hukema; Oliver Stork; Mónica Santos
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

Review 5.  Fragile X spectrum disorders.

Authors:  Reymundo Lozano; Carolina Alba Rosero; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 6.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

7.  Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands.

Authors:  Lisa Cordeiro; Floridette Abucayan; Randi Hagerman; Flora Tassone; David Hessl
Journal:  Intractable Rare Dis Res       Date:  2015-08

8.  Fragile X- associated Neuropsychiatric Disorders: A Case Report.

Authors:  Maria Melinda Tan; Jeanne Barbara Dy; Maria Jimena Salcedo-Arellano; Flora Tassone; Randi J Hagerman
Journal:  Future Neurol       Date:  2019-05-24

9.  A 3' untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR.

Authors:  Joshua A Suhl; Ravi S Muddashetty; Bart R Anderson; Marius F Ifrim; Jeannie Visootsak; Gary J Bassell; Stephen T Warren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

Review 10.  Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene.

Authors:  Maitane Barasoain; Gorka Barrenetxea; Iratxe Huerta; Mercedes Télez; Begoña Criado; Isabel Arrieta
Journal:  Genes (Basel)       Date:  2016-12-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.